Mesoblast Limited (LWB) — Cash Flow-to-Debt Ratio
Mesoblast Limited (LWB) has a Cash Flow-to-Debt Ratio of -0.10x as of June 2023, meaning its operating cash flow of €-16.28 Million could theoretically repay 0% of its total liabilities (€167.58 Million) in one year. See Mesoblast Limited (LWB) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Mesoblast Limited Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Mesoblast Limited across 12 annual periods. For the full cash flow conversion analysis, see Mesoblast Limited (LWB) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for Mesoblast Limited (2014–2025)
Year-by-year debt coverage analysis for Mesoblast Limited. Check Mesoblast Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.27x | €-49.95 Million | €187.24 Million | ▼ -3.9% |
| 2024 | -0.26x | €-48.46 Million | €188.80 Million | ▲ +32.0% |
| 2023 | -0.38x | €-63.27 Million | €167.58 Million | ▲ +5.2% |
| 2022 | -0.40x | €-65.78 Million | €165.10 Million | ▲ +35.4% |
| 2021 | -0.62x | €-100.75 Million | €163.32 Million | ▼ -101.7% |
| 2020 | -0.31x | €-56.37 Million | €184.28 Million | ▲ +9.5% |
| 2019 | -0.34x | €-57.79 Million | €171.06 Million | ▲ +34.1% |
| 2018 | -0.51x | €-75.01 Million | €146.44 Million | ▲ +25.5% |
| 2017 | -0.69x | €-95.47 Million | €138.92 Million | ▼ -21.7% |
| 2016 | -0.56x | €-88.00 Million | €155.86 Million | ▼ -75.3% |
| 2015 | -0.32x | €-101.04 Million | €313.78 Million | ▼ -32.8% |
| 2014 | -0.24x | €-74.91 Million | €308.95 Million | — |